Cervical lymph node relapses of head-and-neck squamous cell carcinoma: Is brachytherapy a therapeutic option?

Citation
Maa. Bollet et al., Cervical lymph node relapses of head-and-neck squamous cell carcinoma: Is brachytherapy a therapeutic option?, INT J RAD O, 51(5), 2001, pp. 1305-1312
Citations number
30
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
ISSN journal
03603016 → ACNP
Volume
51
Issue
5
Year of publication
2001
Pages
1305 - 1312
Database
ISI
SICI code
0360-3016(200112)51:5<1305:CLNROH>2.0.ZU;2-G
Abstract
Purpose: To report the results of interstitial brachytherapy (IBT) without salvage surgery for isolated cervical lymph node relapses. Patients and Methods: From 1970 to 1989, 84 patients were treated; 76 patie nts had relapsed in sites of previous external beam radiation. In 72 patien ts, IBT was sole salvage treatment (mean, 56.5 Gy). In 12 patients IBT (mea n, 38 Gy) was combined with further external beam radiotherapy (mean, 41 Gy ). Results: Local control in the neck was 49% at 1 year, 31% at 2 years, and 0 % at 5 years. Overall survival was 33% at 1 year, 13 % at 2 years, and 1 % at 5 years. Significant toxicity occurred in 35% (7% fatal). Multivariate a nalysis shows survival after salvage was better for patients who had achiev ed initial control for greater than or equal to 18 months before relapse (0 % vs. 13% at 3 years, p < 0.0002). Lymph node control was better for patien ts who received total salvage dose <greater than or equal to>60 Gy (0% vs. 56% at 3 years, p = 0.0004). Conclusion: Given its poor efficiency and its toxicity, IBT must be conside red only when surgery is contraindicated and if lymph node relapse occurs a fter a minimal interval of 18 months. (C) 2001 Elsevier Science Inc.